Publication: Activation of nuclear factor kappa B in peripheral blood mononuclear cells from malaria patients
1
Issued Date
2012-06-12
Resource Type
ISSN
14752875
Other identifier(s)
2-s2.0-84861944888
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Malaria Journal. Vol.11, (2012)
Suggested Citation
Chuchard Punsawad, Srivicha Krudsood, Yaowapa Maneerat, Urai Chaisri, Noppadon Tangpukdee, Emsri Pongponratn, Kwannan Nantavisai, Rachanee Udomsangpetch, Parnpen Viriyavejakul Activation of nuclear factor kappa B in peripheral blood mononuclear cells from malaria patients. Malaria Journal. Vol.11, (2012). doi:10.1186/1475-2875-11-191 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/14306
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Activation of nuclear factor kappa B in peripheral blood mononuclear cells from malaria patients
Other Contributor(s)
Abstract
Background: Malaria parasites and their products can activate a specific immune response by stimulating cytokine production in the hosts immune cells. Transcription nuclear factor kappa B (NF-?B) is an important regulator for the control of many pro-inflammatory genes, such as interleukin-1 (IL-1) and tumor necrosis factor (TNF). The activation and expression of NF-?B p65 in peripheral blood mononuclear cells (PBMCs) of malaria patients were investigated and correlated with the levels of IL-10 and TNF to study the nature of NF-?B p65 and its linkage to inflammatory cytokines. Methods: The sample group comprised 33 patients admitted with malaria caused by Plasmodium vivax (n = 11), uncomplicated Plasmodium falciparum (n = 11), and complicated Plasmodium falciparum (n = 11). Peripheral blood was collected at admission and on day 7 for PBMC isolation. Healthy subjects were used as a control group. The expressions of NF-?B p65 in the PBMCs from malaria patients and the plasma levels of IL-10 and TNF were measured by using enzyme-linked immunosorbent assay (ELISA). The immunofluorescence technique was used to determine NF-?B nuclear translocation. Results: At admission, patients with P. vivax and uncomplicated P. falciparum had significantly elevated phospho- F-?B p65 levels in the PBMCs compared with those of healthy controls. However, patients with complicated P. falciparum malaria had decreased levels of phospho-NF-?B p65. On day 7 post-treatment, significantly increased phospho-NF-?B p65 was found in the PBMCs of patients with complicated P. falciparum, compared with healthy controls. The plasma level of IL-10 was elevated in day 0 in patients with complicated P. falciparum malaria and was found to be negatively correlated with phospho-NF-?B p65 level (r s = ?0.630, p = 0.038). However, there was no correlation between phospho-NF-?B p65 expression and TNF level in patients with complicated P. falciparum malaria. Conclusions: This is the first report demonstrating alterations in NF-?B p65 activity in the PBMCs of malaria patients. The altered lower features of NF-?B p65 in the PBMCs of patients with complicated P. falciparum at admission could be due to a suppressive effect of high IL-10 associated with complicated P. falciparum malaria. © 2012 Punsawad et al.; licensee BioMed Central Ltd.